[Form 4] STRYKER CORP Insider Trading Activity

Rhea-AI Filing Summary

Stryker Corp (SYK) director Ronda E. Stryker reported open‑market sales of common stock on 11/05–11/06/2025. The trades were executed in multiple tranches at weighted‑average prices between $349.455 and $359.80 per share.

Following these transactions, 2,702,108 shares were beneficially owned indirectly by a Revocable Trust. Additional holdings shown include 13,578,805 shares indirectly by the L. Lee Stryker Trust, 37,600 shares indirectly by the 1988 William D. Johnston Trust, and 1,213 shares held directly.

Insights

Insider Transactions Analyst

Large insider sale: director sold 520,000 shares over two days; sizable remaining indirect holdings disclosed.

The filing reports multiple open-market sales (code "S") of **Stryker** common stock by a **Director** on 11/05/2025 and 11/06/2025, totaling 520,000 shares across weighted-average price ranges. Individual tranche prices span roughly $349.46 to $359.80, with each tranche’s exact ranges provided. Post-transaction, indirect holdings by the reporting person’s **Revocable Trust** show 2,702,108 shares. Additional beneficial holdings listed include 13,578,805 shares by the **L. Lee Stryker Trust**, 37,600 shares by the **1988 William D. Johnston Trust**, and 1,213 shares held directly.

Form 4 signals a change in beneficial ownership, not company operations. Still, the absolute size of the sale is large for a single insider across two days. The sales were executed in numerous trades with disclosed weighted-average prices and ranges, which is consistent with standard reporting. No 10b5‑1 plan usage is indicated in the disclosure.

Items to watch: any subsequent Form 4s indicating continued selling, updates to beneficial ownership levels, or future indication of a Rule 10b5‑1 plan. The next weeks through the upcoming quarter (Q4 2025 to Q1 2026) are the practical window to monitor for additional transactions or changes.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

STRYKER RONDA E

(Last) (First) (Middle)

1941 STRYKER WAY

(Street)

PORTAGE MI 49002

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
STRYKER CORP [ SYK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/05/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/05/2025		S		19,973	D	$354.13(1)	3,202,135	I	By Revocable Trust
Common Stock	11/05/2025		S		22,360	D	$354.94(2)	3,179,775	I	By Revocable Trust
Common Stock	11/05/2025		S		29,391	D	$356.16(3)	3,150,384	I	By Revocable Trust
Common Stock	11/05/2025		S		67,906	D	$357.06(4)	3,082,478	I	By Revocable Trust
Common Stock	11/05/2025		S		72,208	D	$357.89(5)	3,010,270	I	By Revocable Trust
Common Stock	11/05/2025		S		31,809	D	$358.68(6)	2,978,461	I	By Revocable Trust
Common Stock	11/05/2025		S		180	D	$359.79(7)	2,978,281	I	By Revocable Trust
Common Stock	11/06/2025		S		396	D	$349.95(8)	2,977,885	I	By Revocable Trust
Common Stock	11/06/2025		S		3,819	D	$351.3(9)	2,974,066	I	By Revocable Trust
Common Stock	11/06/2025		S		68,108	D	$352.45(10)	2,905,958	I	By Revocable Trust
Common Stock	11/06/2025		S		141,052	D	$353.17(11)	2,764,906	I	By Revocable Trust
Common Stock	11/06/2025		S		36,390	D	$354.13(12)	2,728,516	I	By Revocable Trust
Common Stock	11/06/2025		S		24,654	D	$355.1(13)	2,703,862	I	By Revocable Trust
Common Stock	11/06/2025		S		1,754	D	$355.8(14)	2,702,108	I	By Revocable Trust
Common Stock								13,578,805	I	By L. Lee Stryker Trust
Common Stock								1,213	D
Common Stock								37,600	I	By 1988 William D. Johnston Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $353.485 to $354.475, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.

2. The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $354.48 to $355.47, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.

3. The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $355.48 to $356.475, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.

4. The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $356.48 to $357.47, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.

5. The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $357.48 to $358.475, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.

6. The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $358.48 to $359.23, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.

7. The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $359.79 to $359.80, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.

8. The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $349.455 to $350.195, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.

9. The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $350.71 to $351.69, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.

10. The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $351.73 to $352.695, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.

11. The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $352.70 to $353.695, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.

12. The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $353.70 to $354.695, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.

13. The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $354.71 to $355.68, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.

14. The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $355.76 to $355.84, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.

Remarks:

Exhibit 24, Power of Attorney, is attached.

	/s/ Austin Y. Ke, attorney-in-fact for Ronda E. Stryker	11/07/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Stryker (SYK) disclose in this filing?

A Form 4 reporting open‑market sales of Stryker common stock by director Ronda E. Stryker on 11/05–11/06/2025.

What prices were the SYK shares sold at?

Sales occurred in tranches with weighted‑average prices ranging from $349.455 to $359.80 per share.

How many SYK shares did the reporting person hold after the transactions?

2,702,108 shares were beneficially owned indirectly by a Revocable Trust following the reported trades.

What other holdings were listed for the reporting person?

The filing also shows 13,578,805 shares indirectly by the L. Lee Stryker Trust, 37,600 shares indirectly by the 1988 William D. Johnston Trust, and 1,213 shares held directly.

Were these Form 4 sales executed as single prices or ranges?

Each line reflects a weighted‑average sale price, with transactions executed across disclosed price ranges for each tranche.

What is the reporting person’s relationship to Stryker?

Ronda E. Stryker is listed as a Director of Stryker Corp.